Investigational Site Number 203003

Brno 63800

0 studies enrolling now · 2 studies all time

What they study most

Ankylosing Spondylitis, Atherosclerotic Cardiovascular Disease

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis — Completed